Evidence map›Paper›PMID 40700381›Full record

ArticlePloS one2025

Barriers to early and effective overactive bladder management in male patients with lower urinary tract symptoms.

Paul Rasner, Maria Arcila-Ruiz, José Ailton Fernandes Silva, Umaphorn Nuanthaisong, Sung Yung Cho, Eric Chung

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Health Disparities and Overactive Bladder: Bridging the Gap.Current bladder dysfunction reports · 2026
    Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Paul RasnerUrological Department, Moscow State University of Medicine and Dentistry, Moscow, Russia.
Maria Arcila-RuizDepartment of Urology, Hospital Universitario San Ignacio, Bogota, Colombia.ORCID https://orcid.org/0009-0003-7358-4000
José Ailton Fernandes SilvaDepartment of Urology, Pedro Ernesto University Hospital-State University of Rio de Janeiro, Rio de Janeiro, Brazil.
Umaphorn NuanthaisongFaculty of Medicine, Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.
Sung Yung ChoDepartment of Urology, Seoul National University Hospital-Seoul National University College of Medicine, Seoul, South Korea.
Eric ChungDepartment of Urology, Princess Alexandra Hospital, The University of Queensland, Brisbane, Australia.ORCID https://orcid.org/0000-0003-3373-3668

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Overactive bladder is underdiagnosed and undertreated in men as symptoms overlap with benign prostatic obstruction. This study identified barriers urologists encountered in effectively managing overactive bladder in men with lower urinary tract symptoms. 60 urologists recruited across Australia, Brazil, Colombia, Russia, South Korea and Thailand via convenience sampling participated in in-depth interviews. They were asked about their understanding and management of overactive bladder in men with lower urinary tract symptoms. Thematic analysis identified six themes: (1) overactive bladder diagnosis in men with lower urinary tract symptoms is complicated by the multi-factorial causes of storage symptoms; (2) patient-reported outcome tools are underutilized by urologists; (3) stigmatization and normalization of overactive bladder discourage men from seeking care; (4) challenges exist in tracking overactive bladder symptoms and in patient-urologist communication; (5) the underestimation of overactive bladder contributes to the non-urgency of its management; and (6) urologists may not fully appreciate the trade-offs between different overactive bladder treatments. Encouraging patient-reported outcome tool usage and differentiating the safety profiles of antimuscarinics and beta-3 agonists may facilitate timelier overactive bladder diagnosis and increase confidence in adding-on treatment.

Indexed as

Lower Urinary Tract SymptomsUrinary Bladder, OveractiveAdultHumansMaleMiddle AgedMuscarinic AntagonistsPatient Reported Outcome MeasuresUrologistsMuscarinic Antagonists

Identifiers

PMID40700381
PMCPMC12286356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.